Your browser doesn't support javascript.
loading
Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: results from a randomised phase III trial (FUTURE 1).
Strand, Vibeke; Mease, Philip; Gossec, Laure; Elkayam, Ori; van den Bosch, Filip; Zuazo, James; Pricop, Luminita; Mpofu, Shephard.
Afiliação
  • Strand V; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA.
  • Mease P; Swedish Medical Center, University of Washington, Seattle, Washington, USA.
  • Gossec L; Department of Rheumatology, Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS), AP-HP, Pitié Salpêtrière Hospital, Paris, France.
  • Elkayam O; Department of Rheumatology, Tel Aviv Medical Center, "Sackler" Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • van den Bosch F; Department of Rheumatology, University of Ghent, Ghent, Belgium.
  • Zuazo J; Novartis Pharma AG, Basel, Switzerland.
  • Pricop L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Mpofu S; Novartis Pharma AG, Basel, Switzerland.
Ann Rheum Dis ; 76(1): 203-207, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27169431
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Fatores Imunológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Fatores Imunológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article